Middle East & Africa Aquatic Veterinary Market Size and Forecast (2021 - 2031)

The Middle East & Africa Aquatic Veterinary Market is projected to grow significantly, reaching an estimated US$ 95.2 million by 2031, up from US$ 78.9 million in 2024. This growth represents a compound annual growth rate (CAGR) of 2.8% from 2025 to 2031, driven by various factors influencing the demand for aquatic veterinary services in the region.

Executive Summary and Market Analysis

The aquatic veterinary market in the Middle East & Africa is categorized into several key regions, including Saudi Arabia, the UAE, South Africa, and the broader Rest of MEA. The increasing demand for aquatic veterinary services is largely attributed to advancements in the aquaculture sector, socioeconomic factors, environmental challenges, and innovations in veterinary science. Governments across the region are actively promoting aquaculture as a means to enhance food security and stimulate economic growth. For example, in February 2021, the Foundation for Food and Agriculture Research (FFAR) allocated over US$790,000 to develop a vaccine delivery system aimed at preventing the tilapia lake virus and other diseases affecting aquaculture. Such initiatives highlight the critical need for veterinary expertise to support sustainable practices in aquaculture.

Strategic Insights

Market Segmentation Analysis

The Middle East & Africa Aquatic Veterinary Market can be segmented based on various criteria:

• By Type: The market is divided into Diagnostic and Treatment segments, with the Treatment segment leading in 2024.
• By Diagnostic Type: This includes Serological, Molecular Diagnosis, DNA Sequencing, and other diagnostics, where Molecular Diagnosis was the dominant segment in 2024.
• By Treatment Type: The market is further segmented into Vaccines, Medications, and Supplements, with Medications taking the lead in 2024.
• By Species: The market includes Fish, Crustaceans, Mollusca, and others, with Fish being the predominant species in 2024.
• By Disease Source: This includes Bacterial, Viral, Parasites, and others, where Bacterial diseases were the most significant in 2024.
• By Route of Administration: The market is segmented into Water Medication, Medicated Feed, and other routes, with Water Medication being the most common method in 2024.

Market Outlook

Innovations in genomic tools, such as CRISPR/Cas gene editing and RNA interference, are becoming increasingly vital for enhancing disease resistance in aquatic species. These technologies help to lower mortality rates and reduce the costs associated with veterinary interventions. Research conducted in 2024 on CRISPR applications in shrimp and fish has shown promising results, with trials indicating a reduction in mortality rates by up to 50% for strains resistant to viruses like the white spot syndrome virus (WSSV).

Additionally, WorldFish's genomic sequencing of tilapia lake virus (TiLV) isolates in 2024 has paved the way for targeted vaccine development, with field tests planned for 2026 in Bangladesh. The introduction of transgenic fish, such as the AquAdvantage salmon, which is genetically modified for faster growth, exemplifies the practical application of genetic modification in aquaculture to enhance production efficiency.

Emerging genomic tools also facilitate in-depth studies of fish pathogens and host-pathogen interactions, which are essential for developing next-generation vaccines and targeted immunostimulants that can reduce reliance on antibiotics. Furthermore, biotechnology is advancing the production of recombinant proteins and novel vaccines tailored for aquatic species, thereby improving disease prevention and control.

Cryopreservation techniques for gametes and embryos are also crucial for conserving genetic diversity and preserving endangered or economically significant aquatic species. Innovations aimed at producing sterile fish help mitigate ecological risks associated with the escape of genetically modified fish into natural ecosystems. These advancements enable veterinarians to collaborate with geneticists, fostering opportunities for sustainable breeding programs that aim to minimize disease outbreaks and align with global sustainability goals, particularly in high-production regions like Southeast Asia.

Country Insights

The Middle East & Africa Aquatic Veterinary Market is further segmented by country, with significant contributions from Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Notably, South Africa held the largest market share in 2024.

The South African Veterinary Strategy (2016-2026) aims to enhance animal health services, including those for aquatic species, to contribute effectively on a global scale. In 2022, the Onderstepoort Aquatic Animal Health and Veterinary Unit was established, focusing on research, training, and disease control. Initiatives like the World Aquatic Veterinary Medical Association's CertAqV emphasize competencies in pathobiology and biosecurity, with workshops planned for Africa in 2023/24. Additionally, regional networks such as the Aquatic Animal Health Laboratory Network, launched in Pretoria in 2023, aim to strengthen disease surveillance.

In 2020, veterinarians developed a three-tiered flagging system for tilapia health, adopted by the Tilapia Farmers Association to enhance biosecurity and grading, addressing outbreaks of diseases like Koi herpesvirus and Epizootic Ulcerative Syndrome.

Company Profiles

Key players in the Middle East & Africa Aquatic Veterinary Market include Thermo Fisher Scientific Inc, Merck KGaA, Zoetis Inc, Virbac SA, Phibro Animal Health Corp, HIPRA SA, Indian Immunologicals Ltd, Esox Biologics Ltd, Ceva Polchem Pvt Ltd, and Aquatic Diagnostics Ltd. These companies are employing various strategies, including expansion, product innovation, and mergers and acquisitions, to deliver innovative products and increase their market share.